Subtopic Deep Dive
NOD2 Genetics in Crohn's Disease
Research Guide
What is NOD2 Genetics in Crohn's Disease?
NOD2/CARD15 frameshift and missense mutations confer susceptibility to ileal Crohn's disease within inflammatory bowel disease.
Mutations in NOD2 explain 20-30% of familial Crohn's disease risk, initiating IBD genetics research (Jostins et al., 2012). Studies link these variants to impaired bacterial sensing and ileal inflammation. Over 100 papers explore NOD2 penetrance and interactions since 2001.
Why It Matters
NOD2 discovery enabled genetic risk stratification for Crohn's patients, guiding ileal disease prediction (Silverberg et al., 2005). It revealed host-microbe genetic interactions shaping IBD architecture, influencing 38+ susceptibility loci (Jostins et al., 2012; Liu et al., 2015). Functional studies support microbiome-targeted therapies by clarifying NOD2's role in dysbiosis (Morgan et al., 2012).
Key Research Challenges
Low Penetrance Variability
NOD2 mutations show incomplete penetrance, varying by population and environment (Jostins et al., 2012). Challenges quantify gene-environment effects on ileal Crohn's risk. No models predict individual susceptibility from variants alone.
Functional Mechanism Gaps
Mutant NOD2 impairs NF-κB signaling and bacterial clearance, but ileal specificity remains unclear (Baumgart and Sandborn, 2012). Studies lack direct links to microbiome shifts in patients (Morgan et al., 2012). Therapeutic restoration of NOD2 function unproven.
Gene-Environment Interactions
Smoking and diet modulate NOD2 risk, complicating heritability estimates (Liu et al., 2015). Large cohorts needed to parse interactions with 38 IBD loci. Current GWAS overlook rare NOD2 modifiers.
Essential Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
Luke Jostins, Stephan Ripke, Rinse K. Weersma et al. · 2012 · Nature · 4.8K citations
Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology
Mark S. Silverberg, Jack Satsangi, Tariq Ahmad et al. · 2005 · Canadian Journal of Gastroenterology · 3.3K citations
The discovery of a series of genetic and serological markers associated with disease susceptibility and phenotype in inflammatory bowel disease has led to the prospect of an integrated classificati...
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
Xochitl C. Morgan, Timothy L. Tickle, Harry Sokol et al. · 2012 · Genome biology · 2.7K citations
Abstract Background The inflammatory bowel diseases (IBD) Crohn's disease and ulcerative colitis result from alterations in intestinal microbes and the immune system. However, the precise dysfuncti...
Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations
Jimmy Z. Liu, Suzanne van Sommeren, Hailiang Huang et al. · 2015 · Nature Genetics · 2.7K citations
Crohn's disease
Daniel C. Baumgart, William J. Sandborn · 2012 · The Lancet · 2.1K citations
The Microbiome in Inflammatory Bowel Disease: Current Status and the Future Ahead
Aleksandar D. Kostic, Ramnik J. Xavier, Dirk Gevers · 2014 · Gastroenterology · 1.7K citations
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis
Gert Van Assche, Axel Dignaß, Julián Panés et al. · 2010 · Journal of Crohn s and Colitis · 1.5K citations
peer reviewed
Reading Guide
Foundational Papers
Start with Jostins et al. (2012) for IBD genetic architecture including NOD2; Silverberg et al. (2005) for clinical-genetic classification; Baumgart and Sandborn (2012) for Crohn's pathogenesis overview.
Recent Advances
Liu et al. (2015) for 38 loci confirming NOD2; Guan (2019) for pathogenesis update; Kostic et al. (2014) for microbiome context.
Core Methods
GWAS for variant discovery (Jostins et al., 2012); NF-κB assays for function; 16S sequencing for host-microbe links (Morgan et al., 2012).
How PapersFlow Helps You Research NOD2 Genetics in Crohn's Disease
Discover & Search
PapersFlow's Research Agent uses searchPapers to find NOD2 Crohn's papers, citationGraph to map Jostins et al. (2012) influences, and findSimilarPapers for ileal susceptibility variants. exaSearch uncovers hidden gene-environment studies.
Analyze & Verify
Analysis Agent applies readPaperContent on Jostins et al. (2012) to extract variant odds ratios, verifyResponse with CoVe for mutation penetrance claims, and runPythonAnalysis for GWAS meta-analysis stats using pandas on allele frequencies. GRADE grading scores NOD2 evidence as high for ileal Crohn's.
Synthesize & Write
Synthesis Agent detects gaps in NOD2-microbiome links post-Morgan et al. (2012), flags contradictions in penetrance across Liu et al. (2015). Writing Agent uses latexEditText for methods sections, latexSyncCitations for 20+ refs, latexCompile for polished reviews, exportMermaid for genetic interaction diagrams.
Use Cases
"Run stats on NOD2 variant frequencies in Crohn's GWAS datasets."
Research Agent → searchPapers('NOD2 Crohn's GWAS') → Analysis Agent → runPythonAnalysis(pandas aggregation of allele counts from Jostins 2012 + Liu 2015) → matplotlib plots of penetrance ORs.
"Draft LaTeX review of NOD2 ileal Crohn's genetics."
Research Agent → citationGraph('Jostins 2012') → Synthesis Agent → gap detection → Writing Agent → latexEditText(intro) → latexSyncCitations(15 papers) → latexCompile → PDF with figures.
"Find code for NOD2 functional assays from papers."
Research Agent → searchPapers('NOD2 NF-κB assay code') → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → verified simulation scripts.
Automated Workflows
Deep Research workflow scans 50+ NOD2 papers via searchPapers → citationGraph → structured report on ileal risk loci (Jostins et al., 2012). DeepScan applies 7-step CoVe to verify mutation-microbiome claims from Morgan et al. (2012). Theorizer generates hypotheses on NOD2-smoking interactions from Liu et al. (2015) loci.
Frequently Asked Questions
What defines NOD2 mutations in Crohn's?
Frameshift (1007fs) and missense (R702W, G908R) variants in NOD2/CARD15 increase ileal Crohn's risk up to 40-fold (Jostins et al., 2012). They disrupt bacterial peptidoglycan sensing.
What methods study NOD2 function?
GWAS identify variants; NF-κB reporter assays test signaling defects (Silverberg et al., 2005). Microbiome sequencing links to dysbiosis (Morgan et al., 2012).
What are key NOD2 papers?
Jostins et al. (2012, 4764 citations) maps IBD architecture; Silverberg et al. (2005, 3339 citations) integrates genetics with phenotypes; Liu et al. (2015, 2662 citations) expands to 38 loci.
What open problems remain?
Unresolved: penetrance modifiers, ileal specificity mechanisms, microbiome-NOD2 therapies (Baumgart and Sandborn, 2012; Kostic et al., 2014).
Research Inflammatory Bowel Disease with AI
PapersFlow provides specialized AI tools for your field researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
Start Researching NOD2 Genetics in Crohn's Disease with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
Part of the Inflammatory Bowel Disease Research Guide